NIH-funded research U01 cooperative agreement

Developing advanced tests for monitoring Type 1 diabetes in children

Official title: Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications

Funded at Battelle Pacific Northwest Laboratories · NIH-10891667 · Data updated 2026-11-12

This study is working on new, more accurate tests to measure important proteins and hormones in kids and young adults with Type 1 diabetes, so doctors can better track how the disease is progressing and how well treatments are working.

More Diabetes research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionBattelle Pacific Northwest Laboratories
NIH-funded
Lab location1 site (Richland, United States)
Project startJuly 21, 2023
Project endJune 30, 2027
Funding year2024
Award (this year)$949,078
NIH project number5U01DK137113-02
Project IDNIH-10891667 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children and young adults diagnosed with Type 1 diabetes.

Less likely to help

Patients with Type 2 diabetes or other forms of diabetes may not benefit from this research.

What this research studies

This research focuses on creating reliable tests that measure specific proteins and hormones related to Type 1 diabetes (T1D) in children and young adults. By using advanced mass spectrometry techniques, the project aims to develop assays that can accurately track disease progression and the effectiveness of treatments. These tests will provide crucial information about the body's insulin and glucagon levels, helping healthcare providers make informed decisions about patient care. The goal is to improve monitoring methods that currently rely heavily on less precise antibody-based tests.

Why it matters

Potential benefit: If successful, this research could lead to more accurate monitoring of Type 1 diabetes, allowing for better management and treatment options for affected children.

How similar studies have gone: Previous research has shown promise in using mass spectrometry for similar applications, indicating potential for success in this novel approach.

Where this research is happening

  • Battelle Pacific Northwest Laboratories
    Richland, United States
    Active

Researchers

  • Principal investigator: Qian, Wei-Jun — Battelle Pacific Northwest Laboratories
  • Study coordinator: Qian, Wei-Jun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.